https://doi.org/10.4081/itjm.2013.423

How to select appropriate hemoglobin target levels on health-related quality of life and outcomes for patients with chronic kidney disease?

Vol. 8 No. 3 (2014)
Submitted: 2 August 2013
Accepted: 22 November 2013
Published: 2 December 2013
erythropoietin, erythropoiesis stimulating agents.
Abstract Views: 1070
PDF: 1186
HTML: 255
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Filippo Salvati
filippo.salvati@infinito.it
Department of Internal Medicine, Renzetti Hospital, Lanciano (CH), Italy.
According to the European guidelines and the American Kidney Disease Improving Global Outcomes (KDIGO) guidelines, in dialysis patients with chronic kidney disease (CKD), treatment target hemoglobin (Hb) values should be 11-12 g/dL without exceeding 13 g/dL. Doses of erythropoiesis-stimulating agent therapy should be considered to achieve the target hemoglobin level. Caution is recommended in diabetic CKD patients who do not require dialysis. In patients with ischemic heart disease or a previous history of stroke, possible benefits should be assessed against an increased risk of stroke recurrence, when selecting the Hb level.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

no

How to Cite

Salvati, F. (2013). How to select appropriate hemoglobin target levels on health-related quality of life and outcomes for patients with chronic kidney disease?. Italian Journal of Medicine, 8(3), 158–160. https://doi.org/10.4081/itjm.2013.423

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.